Sutro Biopharma (STRO) Non-Current Deferred Revenue (2017 - 2026)
Sutro Biopharma (STRO) recorded Non-Current Deffered Revenue of $2.03 million in Q4 2025, down 83.8% from $12.54 million a year earlier and down 46.0% from the prior quarter.
Powered by 
Analysis
Sutro Biopharma (STRO) Non-Current Deferred Revenue (2017 - 2026) Analysis & Trends
Starting with Q4 2017, Sutro Biopharma's Non-Current Deffered Revenue history includes 29 quarters.
- Annual Non-Current Deffered Revenue has declined for three straight years, with a five-year compound annual growth rate of -19.8% (FY2020 to FY2025).
- Across earlier years, Non-Current Deffered Revenue came in at $12.54 million in FY2024 (-76.5%), $53.38 million in FY2023 (-40.6%) and $89.89 million in FY2022.
- The Q4 2025 figure is the lowest quarterly Non-Current Deffered Revenue since Q3 2021.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for nine consecutive quarters, with an average decline of 73.1% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 4.6% in Q3 2023, against a decline of 98.3% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.76 million (Q3 2025), $6.91 million (Q2 2025) and $8.57 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Sutro Biopharma | 175.16 Mn | -500.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | 6.91 Mn |
| Mar 31, 2025 | 8.57 Mn |
| Dec 31, 2024 | 12.54 Mn |
| Sep 30, 2024 | 18.00 Mn |
| Jun 30, 2024 | 21.69 Mn |
| Mar 31, 2024 | 46.31 Mn |
| Dec 31, 2023 | 53.38 Mn |
| Sep 30, 2023 | 78.15 Mn |
| Jun 30, 2023 | 79.88 Mn |
| Mar 31, 2023 | 85.05 Mn |
| Dec 31, 2022 | 89.89 Mn |
| Sep 30, 2022 | 74.73 Mn |
| Jun 30, 2022 | 90.00 Mn |
| Sep 30, 2021 | 145,000.00 |
| Jun 30, 2021 | 193,000.00 |
| Mar 31, 2021 | 822,000.00 |
| Dec 31, 2020 | 6.10 Mn |
API Access
Sutro Biopharma Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();